Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company s 5008X Hemodialysis System. This will enable.
Divestments in 2023 are important milestones of the Company s execution against its Portfolio Optimization which are part of the set strategic aspirationsDelivers on commitment to improve leverage.
Change of legal form simplifies the corporate governance structure as a German stock corporation The composition of the Management Board remains as before; the new Supervisory Board assumes office.
Fresenius Medical Care AG & Co. KGaA / Key word(s): Change in ForecastFresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised21-Nov-2023 / 21:28 CET/CESTDisclosure of an inside information a.
EQSAdhoc Fresenius Medical Care AG & Co KGaA Key word Change in Forecast Fresenius Medical Care AG & Co KGaA Favorable settlement agreement with U S government with positive earnings impact o